Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of SHR0410 in Hemodialysis Patients
NCT04099927Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jul 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of SHR0410 in chronic kidney disease (CKD), sponsored by Hengrui. Primary endpoint: Incidence of Treatment-Emergent Adverse Events. Started Jul 2019; status: completed.
02
Drugs
SHR0410
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04099927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04099927.